A polipoprotein A-I (apoA-I) is the primary protein component of HDL. ApoA-I plays a key role in lipid transport and metabolism and may play an important role in mediating several of the atheroprotective effects of HDL. 1 Like plasma levels of HDL cholesterol (HDL-C), 2 plasma levels of apoA-I are inversely associated with risk for coronary heart disease (CHD). 3, 4 Low levels of apoA-I have been identified as an independent risk factor for CHD in a human population lacking traditional risk factors such as total cholesterol Ͼ200 mg/dL or HDL-C Ͻ35 mg/dL. 5 Several studies have shown apoA-I levels to be a similar or even stronger predictor of CHD than HDL-C. 4 -8 Studies in animals have consistently shown that increasing the level of apoA-I has antiatherogenic effects. 1 Despite these data, the relationship between complete apoA-I deficiency and atherosclerosis remains uncertain. Because complete apoA-I deficiency in humans is rare, clinical studies have been limited to isolated cases and small kindreds. Results have been inconsistent; some studies have demonstrated markedly premature CHD in patients with apoA-I deficiency, 9 -15 whereas others have found CHD to be absent. 16 -18 Similar to humans, the effect of apoA-I deficiency on the development of atherosclerosis in animals has not been definitive. ApoA-I Ϫ/Ϫ mice have reduced levels of HDL-C, 19 but when fed a chow diet, they do not spontaneously develop atherosclerosis. 20 Furthermore, even when fed an atherogenic diet, apoA-I Ϫ/Ϫ mice develop only minimal atherosclerosis that is not increased relative to wild-type mice. 20 Chow-fed apoA-I Ϫ/Ϫ /apoB transgenic mice also fail to develop significant atherosclerosis. 21 Only when apoA-I Ϫ/Ϫ /apoB transgenic mice were fed a Western-type diet, which induced a marked increase in non-HDL-C (Ϸ450 mg/dL) and an additional reduction in HDL-C (Ϸ15 mg/dL), was apoA-I deficiency associated with a statistically significant 2-fold increase in atherosclerosis, but even then only in female mice. 21 In one other study, apoA-I Ϫ/Ϫ /apoB-100 transgenic mice were fed a cholate-containing atherogenic diet and found to have a modest 39% increase in atherosclerosis relative to control mice. 22 To test the hypothesis that apoA-I deficiency results in significantly increased atherosclerosis under a modest, physiological atherogenic stimulus, we generated mice that were deficient in both apoA-I and the LDL receptor (apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ ) and fed them a chow diet. Surprisingly, the level of HDL-C in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice was significantly greater than in apoA-I Ϫ/Ϫ mice and was similar to the level of HDL-C seen in wild-type mice. However, when compared with LDLR Ϫ/Ϫ mice, apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice developed significantly greater oxidant stress and atherosclerosis. These studies indicate that apoA-I deficiency promotes atherosclerosis on the background of LDLR deficiency despite the presence of normal levels of HDL-C.
Methods

Animals
ApoA-I Ϫ/Ϫ and LDLR Ϫ/Ϫ mice on a C57BL/6 background were obtained from Jackson Laboratories (Bar Harbor, Maine). Mice were crossed to generate F1 apoA-I ϩ/Ϫ /LDLR ϩ/Ϫ mice. The F1 mice were crossed and genotyped for apoA-I and the LDLR using polymerase chain reaction assays (Jackson Laboratory). ApoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ , apoA-I ϩ/ϩ /LDLR Ϫ/Ϫ , and apoA-I Ϫ/Ϫ /LDLR ϩ/ϩ mice were identified for use in the study. Both male and female mice fed a chow diet from the time of weaning through the time of euthanasia were used in the study. Mice were euthanized by intraperitoneal injection of ketamine/xylazine for collection of plasma and quantitation of atherosclerosis at 10, 16, and 22 months. Because significant sex differences were not observed for either plasma lipids or atherosclerosis, data from male and female mice were combined. Mice were handled according to the guidelines of the University of Pennsylvania Institutional Animal Care and Use Committee.
Plasma Lipid and Lipoprotein Analysis
Plasma cholesterol and triglyceride levels were measured enzymatically on a Cobas Fara II (Roche Diagnostic Systems Inc) using Sigma reagents as previously described. 23 Pooled plasma 200 L from wild-type, LDLR Ϫ/Ϫ , and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice or 400 L pooled from apoA-I Ϫ/Ϫ mice was analyzed by FPLC gel filtration (Amersham Pharmacia Biotech) on 2 Superose 6 columns, as previously described. 24 The cholesterol concentrations in the FPLC fractions were determined using an enzymatic assay (Wako Pure Chemical Industries Ltd). Data for apoA-I Ϫ/Ϫ mice is normalized to 200 L of total pooled plasma, corresponding to the volume used in the other 3 mouse groups. The VLDL, LDL, and HDL FPLC peaks in 22-month-old mice were deconvoluted from the FPLC profile by fitting the sum of 3 Gaussian curves using SAAM II (SAAM Institute).
VLDL (dϽ1.006 mg/mL), LDL (dϭ1.006 to 1.063 mg/mL), and HDL (dϭ1.063 to 1.21) were isolated by sequential ultracentrifugation of 200 L of pooled plasma samples from each mouse group. 25 The lipoprotein fractions were analyzed for total cholesterol, esterified cholesterol, phospholipids, triglycerides, and protein using enzymatic assays (Wako Pure Chemical Industries Ltd and Pierce). Cholesterol values for each lipoprotein fraction were normalized to the total plasma cholesterol values.
SDS-PAGE was performed on VLDL, LDL, and HDL isolated from equal volumes of plasma by sequential ultracentrifugation on a 3% to 20% gradient gel under reducing conditions and stained for protein with GelCode Blue Stain Reagent (Pierce). The relative abundance of apolipoproteins in HDL was determined using densitometry of Coomassie-stained SDS-PAGE gels.
Western Blotting
Samples from 2 to 3 adjacent FPLC lipoprotein fractions were pooled and then subjected to SDS-PAGE under reducing conditions. Proteins were transferred to a nitrocellulose membrane, probed for murine apoA-II with a polyclonal rabbit anti-mouse apoA-II antibody (Biodesign International, Kennebunk, Maine), and detected with a peroxidase-conjugated goat anti-rabbit IgG antibody.
Atherosclerosis
The extent of atherosclerosis in the whole aorta was analyzed en face as described previously. 26 Data are represented as the percent of the total aortic surface area that contained atherosclerotic lesion.
The extent of atherosclerosis in the aortic root was determined using methods previously described. 26 The cross-sectional lesion area from serial sections of aortic roots that were stained with Oil Red O were measured by manual tracing of the lesion, which was identified by a combination of lipid staining and histological morphology. The acquisition of images and the analysis of lesion areas were both performed in a blinded fashion.
Isoprostane Analysis
For isoprostane measurement, total lipids from individual plasma samples were extracted with ice-cold Folch solution and chloroform/ methanol (2:1, vol/vol), as described previously, and the organic phase was dried under nitrogen. 27 The samples were hydrolyzed by the addition of aqueous KOH (15%), and total iPF 2␣ -VI was measured as described previously. 27
Statistical Analysis
The Mann-Whitney test was used for comparisons of plasma lipids, isoprostanes, and atherosclerosis between LDLR Ϫ/Ϫ and apoA-
Results
Plasma Lipids and Lipoproteins
At 10 months of age, both LDLR Ϫ/Ϫ and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had elevated levels of non-HDL-C, which were not significantly different from each other when lipoproteins were separated by standard precipitation of apoB-containing lipoproteins 23 (Table 1 ). The same trend was also observed in the non-HDL (VLDLϩLDL) fractions of these groups when lipoproteins were separated by sequential density ultracentrifugation ( Table 2 ). The elevated level of non-HDL-C in LDLR Ϫ/Ϫ and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice was also apparent when lipoproteins were separated by size using FPLC. Both LDLR Ϫ/Ϫ and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had similarly ele- 
Non-HDL-C/HDL-C vated levels of LDL-C compared with wild-type or apoA-I Ϫ/Ϫ mice (please see Figure I , available online at http://atvb.ahajournals.org).
Ten-month-old apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had moderately lower levels of HDL-C compared with LDLR Ϫ/Ϫ mice as determined by precipitation of apoB containing lipoproteins (Table 1 ) and by sequential density ultracentrifugation (Table  2 ). Interestingly, although the level of HDL-C was somewhat decreased compared with LDLR Ϫ/Ϫ mice, apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice had HDL-C levels that were much greater than apoA-I Ϫ/Ϫ mice and similar to wild-type mice (Tables 1  and 2 ). FPLC demonstrated similar HDL-C profiles in wildtype and LDLR Ϫ/Ϫ mice, whereas apoA-I Ϫ/Ϫ and apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice both had similar, reduced levels of HDL-C in the size range corresponding to HDL that contains apoA-I (please see online Figure I ). It is noteworthy that the HDL peaks in apoA-I Ϫ/Ϫ and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice are shifted to the left, corresponding to larger-sized HDL particles.
There was a graded decrease in HDL-C levels of LDLR Ϫ/Ϫ mice with advancing age, whereas the opposite was observed in the HDL-C levels of apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. At 16 months of age, the level of HDL-C in LDLR Ϫ/Ϫ mice was 82 mg/dL, whereas in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, it was 58 mg/dL (Table 3 ). By 22 months of age, the levels of HDL-C in LDLR Ϫ/Ϫ mice and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were similar, 80Ϯ2.8 mg/dL for LDLR Ϫ/Ϫ versus 74Ϯ2.7 mg/dL for apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice ( Table 4 ). This same trend is also apparent in the FPLC profiles, where the peak corresponding to the population of larger HDL particles seen in apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice increases in size as the mice grow older 
Lipoprotein Composition
The chemical composition of VLDL and LDL (data not shown) and HDL (Table 5 ) isolated by density ultracentrifu- (Table 5 ) similar to what has been reported in apoA-I Ϫ/Ϫ mice 20 (Table 5 ). Because equal volumes of plasma were subjected to FPLC, an increase in apoA-II can also be seen in the lipoprotein profiles of 22-month-old apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice compared with LDLR Ϫ/Ϫ mice ( Figure 1C ).
Aortic Atherosclerosis
Both LDLR Ϫ/Ϫ and apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had increased atherosclerosis with advancing age, but for each age that was investigated, apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had significantly more atherosclerosis than LDLR Ϫ/Ϫ mice ( Figure 2 ). The magnitude of the difference between the 2 groups also increased with advancing age.
At 10 months of age, apoA-I Ϫ/Ϫ mice had nearly undetectable levels of atherosclerosis (data not shown). LDLR Ϫ/Ϫ mice had minimal atherosclerosis, with 1.56% of the aortic surface area containing lesion. ApoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had 2.6 times more atherosclerosis than LDLR Ϫ/Ϫ mice, with 4.06% of the aortic surface area containing lesion (Pϭ0.006) (Figure 2 
Plasma Isoprostanes
Isoprostanes are formed by nonenzymatic free-radical-induced oxidation of arachidonic acid-containing phospholipids in cell membranes and LDL and are an established index of in vivo oxidant stress. 28 To test the hypothesis that apoA-I-deficient mice experienced increased oxidant stress, plasma isoprostanes were measured in 22-month-old apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ and LDLR Ϫ/Ϫ mice (Figure 4 ). ApoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice had a 39% increase in plasma isoprostanes compared with LDLR Ϫ/Ϫ mice (PϽ0.05), indicating that lack of apoA-I was associated with increased oxidant stress.
Discussion
In this report, we demonstrate that apoA-I deficiency resulted in a marked loss of protection against the formation of atherosclerosis in chow-fed LDLR Ϫ/Ϫ mice. LDLR Ϫ/Ϫ mice developed moderate hypercholesterolemia but were relatively resistant to the formation of atherosclerosis; in contrast, apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice developed significant atherosclerosis despite similar non-HDL-C and well-preserved HDL-C levels. This study has some important differences from previous studies of atherosclerosis in apoA-I-deficient mice. 20 -22 We used LDLR Ϫ/Ϫ mice, fed them a chow diet, and carried out our experiment for 22 months to investigate the effects of apoA-I deficiency under a modest atherogenic stimulus. ApoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had only moderately elevated levels of non-HDL-C (Ϸ175 mg/mL), normal levels of HDL-C (Ϸ60 mg/mL), and a non-HDL-C to HDL-C ratio of Ϸ3. Other studies of atherosclerosis and apoA-I deficiency used younger apoA-I Ϫ/Ϫ /apoB transgenic mice that were fed an atherogenic diet, resulting in a marked increase in non-HDL-C (Ϸ450 mg/dL) and extremely low levels of HDL-C (Ϸ15 mg/dL). ApoA-I Ϫ/Ϫ /apoB transgenic mice that were fed an atherogenic diet therefore had a non-HDL-C to HDL-C ratio of Ϸ30, which is an order of magnitude greater than the apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice in this study. We believe that the moderate elevation of non-HDL-C in LDLR Ϫ/Ϫ mice fed chow is more similar to moderate hypercholesterolemia found within typical human populations and is therefore a more physiological condition under which to investigate the effects of apoA-I deficiency on atherosclerosis.
We were initially surprised by the relatively high level of HDL-C present in 10-month-old apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. The levels of HDL-C in previous reports of apoA-I deficiency in other mouse models have been lower. To confirm our results, we used multiple methods to measure HDL-C levels, including precipitation of apoB-containing lipoproteins (defining HDL as a lipoprotein lacking apoB), sequential density ultracentrifugation (defining HDL as a lipoprotein in the density range of 1.063 to 1.21 mg/mL), and FPLC (defining HDL based on size and the presence of apoA-II). Our results from the various methods were in general agreement with each other. When we examined 10-, 16-, and 22-month-old mice, we saw a trend of decreasing levels of HDL-C in LDLR Ϫ/Ϫ mice and increasing levels of HDL-C in apoA-I Ϫ/ Ϫ/LDLR Ϫ/Ϫ mice with advancing age. By 22 months, the levels of HDL-C in the 2 groups were very similar. Taken together, our results demonstrate that (1) apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had significantly higher levels of HDL-C than apoA-I Ϫ/Ϫ mice (4-to 5-fold increase); (2) the levels of HDL-C in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were equivalent to wild-type mice; and (3) by 22 months of age, apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice had HDL-C levels that were similar to LDLR Ϫ/Ϫ mice (Tables 1, 3, and 4). Unlike previous reports of apoA-I deficiency, the mice in our study lacked the LDLR. Our results indicate that in this metabolic milieu, the effect of apoA-I deficiency on HDL-C levels is less dramatic.
ApoA-I Ϫ/Ϫ mice have previously been reported to contain a significant population of HDL particles that are larger than HDL present in wild-type mice and therefore overlap with the LDL size range. 20 The results in our study were consistent with this finding. In apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, apoA-II could be detected in FPLC fractions as early as fraction No. 15, which lies near the center of the LDL size range. In contrast, apoA-II was not detected in fractions earlier than fraction No. 29 in LDLR Ϫ/Ϫ mice (Figure 1 ). Western blotting of FPLC fractions for apoA-II also indicated that the level of apoA-II was considerably increased in the HDL of apoA-I Ϫ/Ϫ / LDLR Ϫ/Ϫ mice compared with LDLR Ϫ/Ϫ mice (Figure 1 ). In addition to larger size, HDLs previously described in apoA-I Ϫ/Ϫ mice were also reported to be enriched in apoA-II, apoA-IV, and apoE. 20 HDL present in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice in our study was similar in composition to that reported in apoA-I Ϫ/Ϫ mice ( Table 5 ). The LDLR has been described to be able to interact with large HDL particles (HDL 1 ) enriched in apoE, 29 the type of particles present in apoA-I Ϫ/Ϫ mice. One possible explanation for the increased levels of HDL-C seen in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, compared with apoA-I Ϫ/Ϫ mice, is that there is no LDLR-mediated clearance of apoE-rich HDL in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice. This may have been responsible for the age-related accumulation of large HDLs in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice, seen both when HDL-C is measured by precipitation of apoB containing lipoproteins as well as in the increase in the peak corresponding to large HDL in the FPLC fractionation. Therefore, as opposed to other models of atherosclerosis associated with apoA-I deficiency in which levels of HDL-C were markedly reduced (12 to 23 mg/dL), HDL-C levels in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice were well maintained and closely approached the HDL-C levels in the LDLR Ϫ/Ϫ mice to which they were being compared. Despite having relatively normal levels of HDL-C, apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice developed up to 5 times more atherosclerosis than LDLR Ϫ/Ϫ mice. This suggests that the proatherogenic effects of apoA-I deficiency may be more than simply the lowering of the level of HDL-C and may be related to effects on the quality of HDL that is present in these mice. ApoA-I and apoA-I-rich HDL have been shown to exhibit several potentially antiatherogenic effects. Lipid-poor apoA-I is the major physiological acceptor of cellular cholesterol via ATP-binding cassette-A1 (ABCA1) 30 and indeed has been shown to stabilize the ABCA1 protein. 31 ApoA-I facilitates selective uptake of HDL cholesterol by the liver by activating lecithin-cholesterol acyltransferase 32 and acting as a specific ligand for SR-BI. 33 ApoA-I has also been shown to exhibit antiatherogenic properties, 34 such as acting as an antioxidant, 35, 36 an antiinflammatory agent, 37 and a stabilizer of prostacyclin. 38 ApoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice have HDL that lacks apoA-I and is enriched in apoA-II. ApoA-II-rich HDL is not protected from oxidation 39 and has been shown to be proatherogenic 40 and proinflammatory. 39 Consistent with this concept, apoA-I deficiency was associated with increased plasma isoprostanes in apoA-I Ϫ/Ϫ /LDLR Ϫ/Ϫ mice in our study. This study demonstrates that apoA-I deficiency results in significantly increased atherosclerosis in chow-fed LDLR Ϫ/Ϫ mice, even in the setting of well-maintained HDL-C levels, and suggests that apoA-I itself, independent of HDL-C, has properties that directly protect against atherosclerosis.
